-
1 .
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
- 저자
- by Subodh Verma; Nitish K Dhingra; Javed Butler; Stefan D Anker; Joao Pedro Ferreira, et al.
- 소스
- Lancet Diabetes and Endocrinology
Lancet Diabetes and Endocrinology, Elsevier, 2021, ⟨10.1016/S2213-8587(21)00292-8⟩
Lancet Diabetes & Endocrinology, 10, 1, pp. 35-45
Lancet Diabetes & Endocrinology, 10, 35-45